WEEI>On Demand>>Dr. George Demetri, Senior Vice President for Experimental Therapeutics

Dr. George Demetri, Senior Vice President for Experimental Therapeutics

Aug 30, 2011|

Dr. George Demetri stops by to talk with John and Gerry and discusses what he does on a daily basis to cure this deadly disease. The doctor also talks about some clinical trials, new advances in personalized medicine and where we are headed in the field of cancer research.

Transcript - will not be 100% accurate

Welcome back my friends this is the WEEI -- and Jimmy Fund radio telephone from Fenway Park 8777381234. You can also -- log on to Jimmy Fund dot org or log on to. W -- dot com slash Jimmy Fund or AT&T is really made it easy for you. You can text K cancer all one word -- cancer to 20222. Looking -- on the bill insurance -- -- reported 2191094. Dollars and every gift makes a difference from ten dollars to 5000 dollars you can become a Jimmy -- all star. If you make gift of 15100 dollars or more it's an exclusive club I'll announce your name. Take a bow to all star will be announced on there all -- -- truly make a difference for adults and children currently battling cancer 8777381234. Where Jimmy -- -- it more. Proposals to Marion alana and Lisa sure we a lot of guys that desperate that to Medina and the two of them the two of them are just the greatest the face. That what they do at the clinic case of the -- when you have Nick Leeson the -- prevalent in the patient and the star of the show. I'm. What more we could say you know no. If that as a movie to pick up the phone -- make a donation I don't know what would -- doctor George Dmitri is the senior vice president for experimental therapeutics. You know you of a very tough act to follow after a lot of I don't know that in -- -- -- these different do the opposite. Telling him what tell me what what experimental therapeutics are what do you do adopt a daily basis to help -- the dreaded disease. Well basically what we do is try to come up with new drugs that work better than the ultra -- years and years ago 1020 years ago and my parents were battling cancer. All we had were things that we found by hit or miss extracts from. You know plant leaves some dirt specimens that might kill some cancer cells but in the process hats -- side effects -- pretty impressive. Nowadays we understand much more about what's driving cancer where the short circuits where the wires crossed. And how could we develop drugs. That specifically shut off the circuits and are safe for the rest of the -- how the process get so much more efficient in the last ten or fifteen or twenty years you know we've learned so much more because of the war on cancer this thing going on since the early 1970s the investment this country in the world let's put into the science of understanding. Biology understanding cancer cells is finally able to be translated into new and effective drugs. That are safe pills that aren't so. Difficult to take that this sort of dreaded intravenous infusions all the time that -- people to come into the clinic so much more fun for music doctor. To see my patients to get McHale. And then just haven't come back once a month once every three months read it and see him every week when need to go through a lot of side. We who doctor that Roland said to us earlier in twenty years Google news you'll get rid of cancer but it -- -- -- bill. And it's control it's like. Avalon is trying to upstage again it but it did it that's that's -- two big event a horrible. Expect that really possible is that fairy tale it. It's really possible because we're already doing it with certain diseases certain kinds of leukemia and certain kinds of intestinal cancers literally I've been following some of my patients the last eleven years. Who would have been dead. Eleven years ago will not stand for this hill. That sort of started this revolution this one pill called -- back. Which was just the first of the match last week the FDA approved a new medicine for about 5% of people with lung cancer the week before that. They proved another pill for about six out of ten people have a type of melanoma. I mean these are untreatable cancers before and now it's coming fast and furious I think it's absolutely reality and it's our job Dana Farber. With the support of the very generous people in New England. To make that a reality we're all in this together. And right at a time when the economy's not great. And the government doesn't have a lot of money to put into the kind of research that we're doing it's more important than ever so that we can really bring this to the people that matter people in our own lives. Doctor to be too much of what you'd do deals with clinical trial it's correct correct. A great deal what you do it is their percentage of the book when you're ready to go to clinical trial obviously you're not necessarily confident but hopeful that this is going to be. And upgraded some former fashion with a -- fewer side effects were more efficient treatment. How often do they work out the way you want them to 10% 50% 80% what yet the old number. With one at a 1010%. Would actually succeed a horrible number up you know who would bet on that unit you bet a 110. That's terrible right -- nowadays if we use the science are trials are hopefully -- that more like 400 to 500. And it's a real predictive factor if we can predict what's gonna work and I can look at pace in the eye and say you know if you were my relative. I would absolutely enter this trial because the science says this should. Have a really good chance for working with you and that's with patients listened to become the Dana Farber for that kind of hope. And they trust us to use the science for their own benefit and this is happening right over there is happening right here in America right over the horizon lab coats are coming up -- medicine to. Cure cancer absolutely. And we're not doing it alone were part of whole international consortium this is some of which is coming out of universities like Harvard Dana Farber is the cancer node at Harvard University so we will reach into the expertise of the chemistry department at Harvard or if we needed. MIT's in counseling a lot of collaborations with them we have collaborations in Australia and France and China you name it we will use where we need -- to try to bring things to people. How much deuce side effects negative side effects impact and delay cures -- -- if you could wave a magic wand and said we can invent what we -- invent. And if there weren't side effects it would be bad. Would you be a lot further down the road. You know not really no cancer look at the drugs we've traditionally is twenty years ago side effects of traditional cancer chemotherapy were pretty bad right now in fact. In medicine there's some of the worst side effects of any medicines used to treat anything. So the fact is we started with a pretty well you know -- -- to implement the new drugs are much better tolerated these new pills. That make it's a little bit of trouble handing for example you know that's and I -- that well but again if it's saving your life it's something we're. Dealing yet specifically right now on this date would you really excited about and when you come back here next year you might have a good story to tell us we. Are so excited about lots of delays now we've just taken first baby steps towards doing that we will develop one drug for one disease but now we're starting to mix and match the drugs and that's where. I would actually be a little bit more optimistic even in chief scientific officer I still have cured my sites if we start to mix and match. These drugs once their FDA approved individually. I think curable com. By mixing them together into what is -- by personalized medicine the personalized medicine is simply understanding an individual's cancer and matching the right drug for that person. But that's matching one drug to one person if we say here's one person but now we need three different drugs yes and we wanna pick the right three for that person. That's will hopefully lead to more -- and that's that's hard to do. But that's why we have all the scientists were so good work you guys stumble across cures like I mean today maybe some cure a hangover something -- and hey -- The Viagra story how you record high blood pressure medicine and look what it sounds that -- noses and little involvement veteran. That don't work sometimes. Stumble across secure for something the only exactly in other words there's this one -- this until I mentioned before it was developed really it's something for the heart in workers' art -- -- -- really helps it make people with leukemia live longer and treat systemic that's -- technically live there. And it's a bunch of them. He -- doctor George -- senior vice president for experimental therapeutics thank you for the work you do think -- in time to talk with us today to thank you for -- -- -- -- 8777381234. -- -- -- -- -- all stars -- role -- -- -- these people donated. A lot of money including 15100 dollars we have 2500 dollars from heavily win Newcastle. New Hampshire about several aspect about. Mike Ribeiro -- mass 15100. Dollars John -- from South Weymouth. 15100. Dollars Jennifer Whitney -- -- a thousand dollars William Paul wall and 1000 dollars to take a bow thank you so much. -- now 8777381234. Gives other updated -- would meter. The RL insurance or is it 2191094. But that's -- -- -- violent movement alright this is the WEEI -- Jimmy -- radio telethon. Live from Fenway --

Audio On Demand

It Is What It Is Cast: Lo…

It Is What It Is Cast: Logan Mankins, the offensive line, and Brandon Spikes' guarantee

WEEI.com's Mike Petraglia and Christopher Price discuss Logan Mankins' breakdown of the offensive line and how it will look without Dante Scarnecchia. They also discussed Mankins' rebuttal to Brandon Spikes.

It Is What It Is Cast: Bill Parcells and Patriots Hall of Fame

WEEI.com's Mike Petraglia and Chris Price discuss Bill Parcells' Patriots Hall of Fame candidacy.

CSNNE's Tom E. Curran Reports From NFL Owners Meetings

Tom Curran calls the show to discuss the Vince Wilfork contract situation. After texting with Vince this morning, Curran says that Vince's camp is possibly trying to put the "genie back in the lamp" and that the possibility of the Pro Bowl DT returning to the team has improved.

Celtics President Danny A…

Celtics President Danny Ainge with Dale and Holley 4-17-14

We wrap up the Celtics season by speaking with Celtics president Danny Ainge about this past season and the team's future.

Wyc Grousbeck, Celtics Owner: Reflects on the Boston Marathon tragedy 4-15-4

Celtics owner Wyc Grousbeck joins Mut and Merloni to discuss and reflect on the Boston Marathon Bombings a year later.

Jackie MacMullan, ESPN Boston, on the Celtics, 4-10-14

Jackie MacMullan talks some Celtics with Mut and Merloni as the season is winding down and the team is positioned to have a high draft pick.

Tim Wakefield on the Red …

Tim Wakefield on the Red Sox tough start 4-23-14

Tim Wakefield discussed the Sox tough start to the season. He is optimistic that the guys can turn it around.

Shabazz Napier joins Joe and Dave as the UConn Huskies are honored at Fenway Park

UConn Point Guard, Shabazz Napier joined the guys for a half inning and talked about his experiences in college, his reasoning behind completing his education, and growing up in Boston.

Jonny Gomes with Joe Castiglione & Rob Bradford after the crazy win at Fenway

Joe & Rob talked to Jonny Gomes after the dramatic run-off win at Fenway over the Orioles.

Pierre McGuire, NBC Sport…

Pierre McGuire, NBC Sports, Bruins- Red Wings 4-22-14

Pierre McGuire of NBC Sports joins the program to talk about Game 3 between the Bruins and the Red Wings. He also discusses the issue of targeting player and weighs in on Matt Cooke's vicious knee hit to Tyson Barrie.

Dale and Holley with Patrice Bergeron live from Detroit

Dale and Michael speak with Patrice Bergeron on the phone from Detroit on Marathon Monday fresh off a Bruins optional skate. Patrice talks about the B's slow start in game one, putting it all together for the team in game two, how the rest of this series might play out, and what this anniversary of the Boston Marathon means to him.

Bruins' Enforcer Shawn Thornton Talk with D&C After Game 2 4-21-14

Thornton joins Dino and Gerry to recap Games 1 and 2, discuss Brendan Smith challenging Chara, and preview Game 3 in Detroit.

Tim Wakefield on the Red …

Tim Wakefield on the Red Sox tough start

Tim Wakefield discussed the Sox tough start to the season. He is optimistic that the guys can turn it around.

Headlines, Headlines, Headlines: Colbert introduced on Letterman

The top stories of the day as recounted by Kirk Minihane. The guys talked about Colbert joining Dave Letterman last night.

Brad Marchand is a flopper 4-23-14

The guys opened the show by discussing Brad Marchand's flop and the Bruins win last night.

Pierre McGuire, NBC Sport…

Pierre McGuire, NBC Sports, Bruins- Red Wings 4-22-14

Pierre McGuire of NBC Sports joins the program to talk about Game 3 between the Bruins and the Red Wings. He also discusses the issue of targeting player and weighs in on Matt Cooke's vicious knee hit to Tyson Barrie.

Daily Diamond: Pittsburgh and Milwaukee clear benches in big brawl, April 22, 2014

Mut and Merloni discuss the latest brawl between the Milwaukee Brewers and the Pittsburgh Pirates

Pierre McGuire, NBC Sports, Previews Bruins-Red Wings 4-18-14

Pierre McGuire of NBC Sports joins the program to talk about the creativity of Red Wings coach Mike Babcock as well as the potential for physical play in the series.

Does anyone really miss J…

Does anyone really miss Jacoby Ellsbury in a Red Sox uniform 4-22-14

We discuss the return of Jacoby Ellsbury to Fenway Park, including why he left Boston, and what the crowd reaction will be for him.

DJ Bean live from Detroit previews Round One Games 3 and 4. 4-22-14

We check in with Mr. Bean live from the D to preview two games of Bruins-Wings action.

What's wrong with the 2014 version of Clay Buchholz? 4-22-14

We discuss the harsh start by Clay Buchholz, and how the turnaround from last season's start has been disturbing to watch if you're a Sox fan/

Rick Middleton joins Plan…

Rick Middleton joins Planet Mikey

Nifty jumps on the Planet for an hour.

Red Sox lose to the Orioles 2-1 on Opening Day

Lou Merloni did play-by-play with Joe Castiglione today and then joined The Planet Mikey Show to talk about what went wrong, and a few things that went right as the Red Sox started their campaign to defend their World Series title.

Chris Price joins John Ryder to talk the Patriots' newest acquisition

WEEI.com's Chris Price joins John Ryder and Chris Villani on Planet Mikey to discuss the signing of Revis Island

Fantasy Football Off-Seas…

Fantasy Football Off-Season Podcast 4

The 4th addition of WEEI’s Fantasy Football Offseason Podcast is loaded and ready. In this week’s conversation Jim Hackett and Pete Davidson of Rotobahn.com dig into the sinking draft stock of Teddy Bridgewater (much too their chagrin), while refocusing and emphasizing the immense scouting work done by Pete on players like Bridgewater, Zach Mettenberger, Blake Bortles, Bishop Sankey & Lache Seastrunk. Also, Jim & Pete touch on news from around the league regarding new Jet, Chris Johnson, Montee Ball in Denver and help you tune out all of the negative noise some in the media are trying to push. We’re not buying! Lots of Football love in this podcast for the Football lover. Enjoy!

Pod Man Rush: DJ Bean and Greg Wyshynski on Bruins-Red Wings

Greg Wyshynski of Yahoo! Sports joins DJ to break down the first-round matchup between the Bruins and Red Wings. Also discussed is Zdeno Chara's Norris candidacy, transparency with voting for the NHL awards and whether the Canadiens will get out of the first round.

Minor Details Ep. 79: The meaning of winning in the minors with Carlos Febles, Evan Lepler

The Red Sox' High-A minor league team in Salem recently had a 16-game winning streak that spanned two seasons. So what? From the standpoint of making prospects better and fostering player development, does that matter? Salem manager Carlos Febles (who managed Salem for the end of their winning streak, but who was also in charge of a 50-87 Single-A Greenville team in 2013) and Salem radio play-by-play man Evan Lepler discuss -- while also touching on a number of prospects in search of the next Earl Weaver and Vinegar Bend Mizell.

Chris Forsberg, ESPN Bost…

Chris Forsberg, ESPN Boston, joins Chris Villani on Easter to talk Celtics

With the season over, Chris Forsberg says the Celtics accomplished what they intended to this year. He also gets into what Rajon Rondo may be thinking heading into his last year in his contract. Danny Ainge has a plan and it'll be interesting to see how this off-season develops.

More from this show

Boston Marathon director …

Boston Marathon director Dave McGillivray 4-22-14

Dave called in to discuss the epic Boston Marathon.

More from this show

Headlines, Headlines, Hea…

Headlines, Headlines, Headlines: David Gregory is tanking 4-22-14

The top stories of the day as recounted by Kirk Minihane. Today the guys discussed David Gregory's tanking Meet The Press ratings.

More from this show

Reflections on Marathon M…

Reflections on Marathon Monday and recapping the race with WEEI's Kirk Minihane

Dale and Michael talk about what Marathon Monday means for them, the tremendous amount of people and positivity today in the Back Bay, and then Kirk Minihane, fresh off 26.2 miles stops by to recap a great experience in today's marathon.

More from this show

A great Marathon Monday 4…

A great Marathon Monday 4-22-14

The guys opened the show by discussing yesterday's Boston Marathon and Kirk's run.

More from this show

Weei Writers